文献速递心力衰竭与心肌病心律失常

房颤对射血分数降低、中间值或保留的心力衰竭患者的影响

Impact of atrial fibrillation in patients with heart failure and reduced, mid-range or preserved ejection fraction.
PubMed 文献 · Heart · 2020-04-27

本研究基于韩国急性心衰前瞻性多中心队列,纳入5414例急性心衰住院患者,按LVEF分为HFrEF、HFmrEF和HFpEF。房颤患病率随EF升高而增加(HFrEF 28.9%、HFmrEF 39.8%、HFpEF 45.2%,趋势P<0.001)。

要点

  • 房颤患病率随射血分数升高而增加,HFpEF中最高(45.2%)。
  • 校正后房颤仅与HFpEF全因死亡风险增加独立相关。
  • 房颤与HFrEF或HFpEF患者卒中风险增加相关。

核心结论

  • 房颤患病率随射血分数升高而增加,在HFpEF中最高。
  • 房颤仅与HFpEF患者全因死亡风险增加独立相关。
  • 房颤与HFrEF或HFpEF患者卒中风险增加相关。

研究设计与样本

  • 韩国急性心衰注册研究为前瞻性、观察性、多中心队列研究,纳入2011年3月至2014年2月急性心衰住院患者。
  • 共纳入5414例患者,HFrEF(LVEF<40%)3182例(58.8%),HFmrEF(LVEF 40%-49%)875例(16.2%),HFpEF(LVEF≥50%)1357例(25.1%)。
  • 随访中位时间4.03年(IQR 1.39-5.58年),期间2806例(51.8%)死亡。

主要发现

  • 房颤患病率HFrEF 28.9%、HFmrEF 39.8%、HFpEF 45.2%,趋势P<0.001。
  • 校正后房颤对全因死亡的HR:HFrEF 1.06(0.93-1.21),HFmrEF 1.10(0.87-1.39),HFpEF 1.22(1.02-1.46)。
  • 全因死亡或再入院复合终点HR:HFrEF 0.97(0.87-1.07),HFmrEF 1.14(0.93-1.38),HFpEF 1.03(0.88-1.19)。
  • 卒中HR:HFrEF 1.53(1.03-2.29),HFmrEF 1.04(0.57-1.91),HFpEF 1.90(1.13-3.20)。
  • 倾向性评分匹配分析后结果相似。

临床怎么用

  • 对HFpEF患者应关注房颤的存在,因其与全因死亡风险增加独立相关。
  • 对HFrEF或HFpEF合并房颤患者,需警惕卒中风险增加。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine the prognostic value of atrial fibrillation (AF) in patients with heart failure (HF) and preserved, mid-range or reduced ejection fraction (EF). METHODS: Patients hospitalised for acute HF were enrolled in the Korean Acute Heart Failure registry, a prospective, observational, multicentre cohort study, between March 2011 and February 2014. HF types were defined as reduced EF (HFrEF, LVEF <40%), mid-range EF (HFmrEF, LVEF 40%-49%) or preserved EF (HFpEF, LVEF ≥50%). RESULTS: Of 5414 patients enrolled, HFrEF, HFmrEF and HFpEF were seen in 3182 (58.8%), 875 (16.2%) and 1357 (25.1%) patients, respectively. The prevalence of AF significantly increased with increasing EF (HFrEF 28.9%, HFmrEF 39.8%, HFpEF 45.2%; p for trend <0.001). During follow-up (median, 4.03 years; IQR, 1.39-5.58 years), 2806 (51.8%) patients died. The adjusted HR of AF for all-cause death was 1.06 (0.93-1.21) in the HFrEF, 1.10 (0.87-1.39) in the HFmrEF and 1.22 (1.02-1.46) in the HFpEF groups. The HR for the composite of all-cause death or readmission was 0.97 (0.87-1.07), 1.14 (0.93-1.38) and 1.03 (0.88-1.19) in the HFrEF, HFmrEF and HFpEF groups, respectively, and the HR for stroke was 1.53 (1.03-2.29), 1.04 (0.57-1.91) and 1.90 (1.13-3.20), respectively. Similar results were observed after propensity score matching analysis. CONCLUSIONS: AF was more common with increasing EF. AF was seen to be associated with increased mortality only in patients with HFpEF and was associated with an increased risk of stroke in patients with HFrEF or HFpEF. TRIAL REGISTRATION NUMBER: NCT01389843.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Son MK, Park JJ, Lim NK, et al. Impact of atrial fibrillation in patients with heart failure and reduced, mid-range or preserved ejection fraction. Heart. 2020. PMID: 32341140. doi:10.1136/heartjnl-2019-316219

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。